ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Offers Coded Serum Panels

May 28, 1982

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

In Brief: Delores Esparza President Elect Of ONS; Brown Demands Jako Retract “Insulting Remarks”

May 13, 1988

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992